Ninnion Therapeutics is a research & development stage company focused on clinical testing and commercialization of novel drug candidates in the emerging field of psychedelic entheogenic medicine.

eauLife AG is a Swiss based startup company developing innovative products for the functional beverage and dietary supplement markets. Preparations are underway for a US launch of glë™, prenatal vitamin beverages that completely replace the need for traditional prenatal multi-vitamin pills.

**SEOUL, Korea, May 29, 2012 /PRNewswire/ -- Samsung BioLogics, a full-service biopharmaceutical contract development & cGMP manufacturing organization, has announced the appointment of Jeremy M. Caudill as Vice President of Global Business Development.. and has global responsibilities for all business development & related activities.Tae-Han Kim, Ph.D., CEO of Samsung BioLogics says: "Jeremy brings an exceptional track record of business development in the biopharmaceutical market combined with an extensive network of senior level decision makers. He is an industry leader and brings to Samsung BioLogics an impressive background including broad international experience...**PRINCETON, N.J. & SEOUL, July 29th 2013 South Korea--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Samsung BioLogics today announced the companies have entered into a 10-year agreement...**SEOUL, South Korea, Oct. 22, 2013 /PRNewswire/ -- Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement...**NEW YORK & SEOUL, Apr. 22, 2014--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Samsung BioLogics today announced the companies will increase the scope of their existing manufacturing agreement...

**CRANBURY, NJ Thursday, October 13, 2011 12:50 PM - Oncobiologics has signed two major agreements worth $80MM. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies. The identity of the client firm was not disclosed due to confidentiality terms in the agreement....

Various Business Development Consulting projects in the pharmaceutical and biotechnology

Executive Management Team Member leading global team of Sales, Licensing, Marketing & Business Development professionals selling technology licensing, development and cGMP manufacturing services to Pharmaceutical and Biotechnology companies. Strategic Business Development responsibilities for collaboration, joint venture partners, alliance management and M&A activities.

Sales & Business Development for cGMP contract manufacturing of recombinant biologics (proteins & antibodies), small molecules, peptides and cell therapy.